Logo image of ILM1.DE

MEDIOS AG (ILM1.DE) Stock Fundamental Analysis

FRA:ILM1 - Deutsche Boerse Ag - DE000A1MMCC8 - Common Stock - Currency: EUR

11.83  +0.03 (+0.25%)

Fundamental Rating

4

ILM1 gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 27 industry peers in the Health Care Providers & Services industry. While ILM1 seems to be doing ok healthwise, there are quite some concerns on its profitability. ILM1 is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year ILM1 was profitable.
ILM1 had a positive operating cash flow in the past year.
ILM1 had positive earnings in each of the past 5 years.
ILM1 had a positive operating cash flow in 4 of the past 5 years.
ILM1.DE Yearly Net Income VS EBIT VS OCF VS FCFILM1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M -40M 60M

1.2 Ratios

The Return On Assets of ILM1 (1.61%) is comparable to the rest of the industry.
With a Return On Equity value of 2.89%, ILM1 perfoms like the industry average, outperforming 44.44% of the companies in the same industry.
ILM1 has a Return On Invested Capital of 3.03%. This is comparable to the rest of the industry: ILM1 outperforms 44.44% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ILM1 is below the industry average of 5.67%.
Industry RankSector Rank
ROA 1.61%
ROE 2.89%
ROIC 3.03%
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ILM1.DE Yearly ROA, ROE, ROICILM1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

1.3 Margins

ILM1 has a Profit Margin of 0.78%. This is in the lower half of the industry: ILM1 underperforms 66.67% of its industry peers.
ILM1's Profit Margin has declined in the last couple of years.
ILM1 has a Operating Margin of 1.96%. This is in the lower half of the industry: ILM1 underperforms 77.78% of its industry peers.
ILM1's Operating Margin has declined in the last couple of years.
ILM1 has a worse Gross Margin (8.91%) than 77.78% of its industry peers.
In the last couple of years the Gross Margin of ILM1 has grown nicely.
Industry RankSector Rank
OM 1.96%
PM (TTM) 0.78%
GM 8.91%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
ILM1.DE Yearly Profit, Operating, Gross MarginsILM1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ILM1 is destroying value.
The number of shares outstanding for ILM1 has been increased compared to 1 year ago.
ILM1 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ILM1 has a worse debt to assets ratio.
ILM1.DE Yearly Shares OutstandingILM1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ILM1.DE Yearly Total Debt VS Total AssetsILM1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 2.98 indicates that ILM1 is not a great score, but indicates only limited risk for bankruptcy at the moment.
ILM1's Altman-Z score of 2.98 is amongst the best of the industry. ILM1 outperforms 81.48% of its industry peers.
The Debt to FCF ratio of ILM1 is 8.28, which is on the high side as it means it would take ILM1, 8.28 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 8.28, ILM1 is doing good in the industry, outperforming 66.67% of the companies in the same industry.
ILM1 has a Debt/Equity ratio of 0.37. This is a healthy value indicating a solid balance between debt and equity.
ILM1 has a Debt to Equity ratio of 0.37. This is amongst the best in the industry. ILM1 outperforms 88.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 8.28
Altman-Z 2.98
ROIC/WACC0.47
WACC6.42%
ILM1.DE Yearly LT Debt VS Equity VS FCFILM1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M 500M

2.3 Liquidity

ILM1 has a Current Ratio of 1.96. This is a normal value and indicates that ILM1 is financially healthy and should not expect problems in meeting its short term obligations.
ILM1's Current ratio of 1.96 is amongst the best of the industry. ILM1 outperforms 88.89% of its industry peers.
ILM1 has a Quick Ratio of 1.42. This is a normal value and indicates that ILM1 is financially healthy and should not expect problems in meeting its short term obligations.
With an excellent Quick ratio value of 1.42, ILM1 belongs to the best of the industry, outperforming 85.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.96
Quick Ratio 1.42
ILM1.DE Yearly Current Assets VS Current LiabilitesILM1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

More info and screens

5

3. Growth

3.1 Past

ILM1 shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -22.32%.
ILM1 shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.00% yearly.
Looking at the last year, ILM1 shows a small growth in Revenue. The Revenue has grown by 5.62% in the last year.
Measured over the past years, ILM1 shows a very strong growth in Revenue. The Revenue has been growing by 29.51% on average per year.
EPS 1Y (TTM)-22.32%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%47.06%
Revenue 1Y (TTM)5.62%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%6.23%

3.2 Future

ILM1 is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 15.69% yearly.
Based on estimates for the next years, ILM1 will show a small growth in Revenue. The Revenue will grow by 4.11% on average per year.
EPS Next Y8.93%
EPS Next 2Y21.1%
EPS Next 3Y15.69%
EPS Next 5YN/A
Revenue Next Year7.6%
Revenue Next 2Y6.04%
Revenue Next 3Y4.17%
Revenue Next 5Y4.11%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ILM1.DE Yearly Revenue VS EstimatesILM1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
ILM1.DE Yearly EPS VS EstimatesILM1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

ILM1 is valuated rather expensively with a Price/Earnings ratio of 20.05.
The rest of the industry has a similar Price/Earnings ratio as ILM1.
ILM1 is valuated rather cheaply when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 7.98, the valuation of ILM1 can be described as very cheap.
Based on the Price/Forward Earnings ratio, ILM1 is valued cheaply inside the industry as 92.59% of the companies are valued more expensively.
ILM1's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.17.
Industry RankSector Rank
PE 20.05
Fwd PE 7.98
ILM1.DE Price Earnings VS Forward Price EarningsILM1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

ILM1's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ILM1 is cheaper than 81.48% of the companies in the same industry.
ILM1's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 11.28
EV/EBITDA 5.93
ILM1.DE Per share dataILM1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ILM1 does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as ILM1's earnings are expected to grow with 15.69% in the coming years.
PEG (NY)2.24
PEG (5Y)N/A
EPS Next 2Y21.1%
EPS Next 3Y15.69%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ILM1!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MEDIOS AG

FRA:ILM1 (6/3/2025, 1:02:07 PM)

11.83

+0.03 (+0.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)05-13 2025-05-13
Earnings (Next)08-13 2025-08-13
Inst Owners39.37%
Inst Owner ChangeN/A
Ins Owners19.96%
Ins Owner ChangeN/A
Market Cap301.78M
Analysts86.15
Price Target28.08 (137.36%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-3.7%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-25.09%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.92%
Valuation
Industry RankSector Rank
PE 20.05
Fwd PE 7.98
P/S 0.16
P/FCF 11.28
P/OCF 8.92
P/B 0.58
P/tB 22.02
EV/EBITDA 5.93
EPS(TTM)0.59
EY4.99%
EPS(NY)1.48
Fwd EY12.54%
FCF(TTM)1.05
FCFY8.87%
OCF(TTM)1.33
OCFY11.21%
SpS74.93
BVpS20.26
TBVpS0.54
PEG (NY)2.24
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.61%
ROE 2.89%
ROCE 4.99%
ROIC 3.03%
ROICexc 3.44%
ROICexgc 14.41%
OM 1.96%
PM (TTM) 0.78%
GM 8.91%
FCFM 1.4%
ROA(3y)2.56%
ROA(5y)2.39%
ROE(3y)3.52%
ROE(5y)3.26%
ROIC(3y)3.26%
ROIC(5y)3.09%
ROICexc(3y)3.82%
ROICexc(5y)3.8%
ROICexgc(3y)12.89%
ROICexgc(5y)11.48%
ROCE(3y)5.38%
ROCE(5y)5.1%
ROICexcg growth 3Y-0.85%
ROICexcg growth 5Y-8.22%
ROICexc growth 3Y-6.07%
ROICexc growth 5Y-23.77%
OM growth 3Y14.45%
OM growth 5Y-8.47%
PM growth 3Y6.91%
PM growth 5Y-18.81%
GM growth 3Y16.82%
GM growth 5Y4.08%
F-Score4
Asset Turnover2.06
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF 8.28
Debt/EBITDA 2.61
Cap/Depr 19.94%
Cap/Sales 0.37%
Interest Coverage 2.86
Cash Conversion 46.37%
Profit Quality 179.07%
Current Ratio 1.96
Quick Ratio 1.42
Altman-Z 2.98
F-Score4
WACC6.42%
ROIC/WACC0.47
Cap/Depr(3y)16.31%
Cap/Depr(5y)50.4%
Cap/Sales(3y)0.24%
Cap/Sales(5y)0.49%
Profit Quality(3y)264.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-22.32%
EPS 3Y11.33%
EPS 5Y-5%
EPS Q2Q%47.06%
EPS Next Y8.93%
EPS Next 2Y21.1%
EPS Next 3Y15.69%
EPS Next 5YN/A
Revenue 1Y (TTM)5.62%
Revenue growth 3Y11.53%
Revenue growth 5Y29.51%
Sales Q2Q%6.23%
Revenue Next Year7.6%
Revenue Next 2Y6.04%
Revenue Next 3Y4.17%
Revenue Next 5Y4.11%
EBIT growth 1Y25.3%
EBIT growth 3Y27.64%
EBIT growth 5Y18.54%
EBIT Next Year110.41%
EBIT Next 3Y33.73%
EBIT Next 5Y29.68%
FCF growth 1Y140.67%
FCF growth 3Y11.42%
FCF growth 5YN/A
OCF growth 1Y136.45%
OCF growth 3Y6.19%
OCF growth 5YN/A